Is this your podcast?
Sign up to track ranks and reviews from iTunes, Stitcher and more
The Peter Attia Drive
Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.
Listen now
Ratings & Reviews
4.8 stars from 3,772 ratings
I love the contents of The Drive, but the current model of distribution is broken. Most of what is now in my feed are short episodes promoting the paid subscription. And each episode starts with four minutes (!!) of ads, and ends with a crazily long disclaimer. I get why both these things are,...Read full review »
Elise Listens via Apple Podcasts · United States of America · 10/21/19
My most favorite podcast
Even tough it gets too technical for me this is really my most favorite podcast on longevity and all things health related. He just induces trust in me
Zeynep Ertan via Apple Podcasts · Turkey · 10/20/19
Amazing
I listen to a lot of podcasts; mostly about cybersecurity since that’s what I do and I have three hours in the car every. I suspended all cyber podcasts until I finish the binge on this. My family history says that I’m most likely to die of heart disease. I’d already sworn that I didn’t want...Read full review »
jporterk via Apple Podcasts · United States of America · 10/20/19
Recent Episodes
In this episode, Kyle Kingsbury, retired UFC fighter and director of human optimization at Onnit, discusses the purpose and meaning that football and MMA gave him but which also acted as a distraction from his inner demons. Kyle opens up about his use of PEDs (steroids, testosterone, HGH) in...
Published 10/21/19
Today's episode of The Qualys is from podcast #26 – AMA #3: supplements, women’s health, patient care, and more. The Qualys is a subscriber-exclusive podcast, released Tuesday through Friday, and published exclusively on our private, subscriber-only podcast feed. Qualys is short-hand for...
Published 10/17/19
In this episode, David Light, CEO of Valisure (the company which alerted the FDA to the Zantac cancer concerns), explains the story behind the recent recalls by manufacturers of ranitidine, a common heartburn medication, sold under the trade name Zantac, due to a potential link to increased...
Published 10/14/19
Do you host a podcast?
Track your ranks and reviews from iTunes, Stitcher and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »